Clinical Trial Update: Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.) [NA]

View source ↗

Summary

A clinical trial evaluating lactulose versus polyethylene glycol for hepatic encephalopathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatic Encephalopathy

Drugs mentioned

• LACTULOSE (Lactulose)
• Polyethylene Glycol (polyethylene glycol)

Snippet

Sponsor: New York Presbyterian Brooklyn Methodist Hospital | Conditions: Hepatic Encephalopathy, HE | NA | Status: WITHDRAWN